» Articles » PMID: 19797074

OmpA of Uropathogenic Escherichia Coli Promotes Postinvasion Pathogenesis of Cystitis

Overview
Journal Infect Immun
Date 2009 Oct 3
PMID 19797074
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Type 1 pilus directs bladder epithelial binding and invasion by uropathogenic Escherichia coli (UPEC) in the initial stage of cystitis, but the bacterial determinants of postinvasion events in the pathogenesis of cystitis are largely undetermined. We show here that the UPEC outer membrane protein A (OmpA), a monomeric, major, integral protein component of the bacterial outer membrane, functions as a critical determinant of intracellular virulence for UPEC, promoting persistent infection within bladder epithelium. Using a murine urinary tract infection (UTI) model, we demonstrate that whereas deletion of the UPEC ompA gene did not disrupt initial epithelial binding and invasion by UPEC, it did preclude completion of the intracellular bacterial community (IBC) pathway, accompanied by diminishing bacterial loads in the bladder. This defect in epithelial persistence of the ompA mutant was enhanced in competitive infections with wild-type UPEC. Microscopic examinations revealed that the ompA mutant formed significantly fewer IBCs, and those that were initiated were unable to progress past the early stages of maturation. These defects could be corrected by complementation of ompA. In addition, expression of ompA during wild-type UTI was sharply increased at time points correlated with IBC development and the arrival of host immune effector cells. Our findings establish OmpA as a key UPEC virulence factor that functions after epithelial invasion to facilitate IBC maturation and chronic bacterial persistence.

Citing Articles

The rise, fall, and resurgence of phage therapy for urinary tract infection.

Zulk J, Patras K, Maresso A EcoSal Plus. 2024; 12(1):eesp00292023.

PMID: 39665540 PMC: 11636367. DOI: 10.1128/ecosalplus.esp-0029-2023.


Genetic requirements for uropathogenic proliferation in the bladder cell infection cycle.

Mediati D, Blair T, Costas A, Monahan L, Soderstrom B, Charles I mSystems. 2024; 9(10):e0038724.

PMID: 39287381 PMC: 11495030. DOI: 10.1128/msystems.00387-24.


Characterization and comparative analysis of the Escherichia marmotae M-12 isolate from bank vole (Myodes glareolus).

Zhurilov P, Andriyanov P, Tutrina A, Razheva I, Liskova E, Gladkova N Sci Rep. 2023; 13(1):13949.

PMID: 37626115 PMC: 10457355. DOI: 10.1038/s41598-023-41223-0.


Synthetic and natural antimicrobials as a control against food borne pathogens: A review.

Farid N, Waheed A, Motwani S Heliyon. 2023; 9(6):e17021.

PMID: 37484319 PMC: 10361103. DOI: 10.1016/j.heliyon.2023.e17021.


SurA-like and Skp-like Proteins as Important Virulence Determinants of the Gram Negative Bacterial Pathogens.

Figaj D, Ambroziak P, Rzepka I, Skorko-Glonek J Int J Mol Sci. 2023; 24(1).

PMID: 36613738 PMC: 9820271. DOI: 10.3390/ijms24010295.


References
1.
Sun T, Zhao H, Provet J, Aebi U, Wu X . Formation of asymmetric unit membrane during urothelial differentiation. Mol Biol Rep. 1996; 23(1):3-11. DOI: 10.1007/BF00357068. View

2.
Weiser J, Gotschlich E . Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun. 1991; 59(7):2252-8. PMC: 258003. DOI: 10.1128/iai.59.7.2252-2258.1991. View

3.
Foxman B . Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002; 113 Suppl 1A:5S-13S. DOI: 10.1016/s0002-9343(02)01054-9. View

4.
Mysorekar I, Hultgren S . Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A. 2006; 103(38):14170-5. PMC: 1564066. DOI: 10.1073/pnas.0602136103. View

5.
Mulvey M, Wilson C, Roth R, Parks W, Heuser J, Hultgren S . Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science. 1998; 282(5393):1494-7. DOI: 10.1126/science.282.5393.1494. View